Alnylam Pharmaceuticals Rings the Opening Bell

ABOUT THIS EVENT

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, visits the Nasdaq MarketSite in Times Square. This month marks Alnylam’s 20th anniversary, and the company is celebrating 20 years of Alnylam leadership and what’s next in the RNAi Revolution.

In honor of the occasion, Yvonne Greenstreet, MBChB, Chief Executive Officer, rings the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore